Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-24 GRIFFITH MELINDA Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2021-06-24 GRIFFITH MELINDA Director Grant or award · Restricted Stock Units +10,000 10,000
2021-06-24 Arno Andrew Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2021-06-24 Arno Andrew Director Grant or award · Restricted Stock Units +10,000 10,000
2021-06-11 Last Andrew J. Director Option exercise +6,993 $3.00 $21K 30,170
2021-06-11 Last Andrew J. Director Option exercise · Warrants +6,993 0
2021-05-07 ANDREWS RONALD ASBURY Chief Executive Officer Option exercise +106,221 219,919
2021-05-07 ANDREWS RONALD ASBURY Chief Executive Officer Option exercise · Restricted Stock Units −106,221 0
2021-04-28 Levine Mitchell S Chief Financial Officer Option exercise +20,000 66,700
2021-04-28 Levine Mitchell S Chief Financial Officer Shares withheld for taxes −4,620 62,080
2021-04-28 Levine Mitchell S Chief Financial Officer Option exercise · Restricted Stock Units −20,000 0
2021-03-19 ANDREWS RONALD ASBURY Chief Executive Officer Purchase +11,000 $4.79 $53K 113,698
2021-02-25 Sundar Padmavathi Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +255,000 $5.34 $1.4M 255,000
2021-02-25 Levine Mitchell S Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +255,000 $5.34 $1.4M 255,000
2021-02-25 ANDREWS RONALD ASBURY Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +500,000 $5.34 $2.7M 500,000
2021-02-25 Ross Douglas T. Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +255,000 $5.34 $1.4M 255,000
2021-02-05 BROADWOOD PARTNERS, L.P. 10% owner Purchase +600,000 $4.50 $2.7M 16,776,484
2021-02-05 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 16,776,484
2021-01-20 BROADWOOD PARTNERS, L.P. 10% owner Purchase +1,460,280 $3.42 $5.0M 16,176,484
2021-01-20 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 16,176,484

Page 14 of 20 · 383 trades